Cor Vasa 2020, 62(Suppl. 1):15-18 | DOI: 10.33678/cor.2020.042

(Specific SARS-CoV-2 myocarditis - does it exist?)

Jan Krejčí
I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně

The COVID-19 pandemic has raised a number of questions that do not have yet a clear answer. One of them is also the etiology of acute myocardial injury, which may be manifested only by troponin level elevation, but sometimes may be associated with the development of left ventricular dysfunction accompanied by symptoms of heart failure. Patients with myocardial injury have been reported to have a worse prognosis than patients with normal troponin levels. It is not clear whether this is the cause of a poor prognosis or the result of a severe course of the disease. It is also not clear what is the etiology of this condition. One of the possibilities is the development of myocarditis, an alternative explanation may be that myocardial damage is caused by a cytokine storm, similar to the so-called septic cardiomyopathy. In this article, some published case reports are briefly analyzed and based on them, the author does not assume that myocardial damage would be caused by specific SARS-CoV-2-induced myocarditis.

Keywords: Acute myocardial injury, COVID-19, Myocarditis, Septic cardiomyopathy

Received: May 12, 2020; Accepted: May 12, 2020; Published: June 22, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejčí J. (Specific SARS-CoV-2 myocarditis - does it exist?). Cor Vasa. 2020;62(Suppl. 1):15-18. doi: 10.33678/cor.2020.042.
Download citation

References

  1. Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636-2648. Go to original source... Go to PubMed...
  2. Trachtenberg BH, Hare JM. Inflammatory Cardiomyopathic Syndromes. Circ Res 2017;121:803-818. Go to original source... Go to PubMed...
  3. Krejčí J, Poloczková H. Zánětlivá onemocnění myokardu. Vnitř Lék 2019;65:636-642. Go to original source... Go to PubMed...
  4. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020 Mar 25;e200950. doi: 10.1001/jamacardio.2020.0950. [Epub ahead of print] Go to original source... Go to PubMed...
  5. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol 2020 Mar 27;e201017. doi: 10.1001/jamacardio.2020.1017. [Epub ahead of print] Go to original source... Go to PubMed...
  6. Li JW, Han TW, Woodward M, et al. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta- -analysis [published online ahead of print, 2020 Apr 16]. Prog Cardiovasc Dis 2020 Apr 16. pii: S0033-0620(20)30080-3. doi: 10.1016/j.pcad.2020.04.008. Go to original source... Go to PubMed...
  7. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J 2020 Mar 16. pii: ehaa190. doi: 10.1093/eurheartj/ehaa190. [Epub ahead of print] Go to original source... Go to PubMed...
  8. Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J 2020 Apr 13. pii: ehaa288. doi: 10.1093/eurheartj/ehaa288. [Epub ahead of print] Go to original source... Go to PubMed...
  9. Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 2020 Apr 10. doi: 10.1007/s15010-020-01424-5. [Epub ahead of print] Go to original source... Go to PubMed...
  10. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-422. Go to original source... Go to PubMed...
  11. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020 Apr 10. doi: 10.1002/ejhf.1828. [Epub ahead of print] Go to original source... Go to PubMed...
  12. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol 2020 Mar 27. doi: 10.1001/jamacardio.2020.1286. [Epub ahead of print] Go to original source... Go to PubMed...
  13. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020 Mar 19. doi: 10.1001/jama.2020.4326. [Epub ahead of print] Go to original source... Go to PubMed...
  14. Chockalingam A, Mehra A, Dorairajan S, Dellsperger KC. Acute left ventricular dysfunction in the critically ill. Chest 2010;138:198-207. Go to original source... Go to PubMed...
  15. Lin H, Wang W, Lee M, et al. Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress. Front Pharmacol 2020;11:210. eCollection 2020. Go to original source... Go to PubMed...
  16. Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive Care 2015;3:48. eCollection 2015. Go to original source... Go to PubMed...
  17. Vasques-Nóvoa F, Angélico-Gonçalves A, Bettencourt N, et al. Myocardial Edema and Remodeling: A Link Between Acute Myocarditis and Septic Cardiomyopathy? J Am Coll Cardiol 2020;75:1497-1498. Go to original source... Go to PubMed...
  18. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol 2018;72:3158-3176. Go to original source... Go to PubMed...
  19. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 2020;45:230-232. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.